New research has uncovered how lipid-rich fluid in the abdomen, known as ascites, plays a central role in weakening the body’s immune response in advanced ovarian cancer.

New research led by scientists in Ireland has uncovered how a fat-rich fluid found in the abdomen of ovarian cancer patients ...

A self-confessed gym-junkie and clean-eater, Gemma Henly's one symptom is what triggered her to seek a second medical opinion ...

The Gazette will host a series of free, virtual panel discussions this week aimed at exploring Iowa's cancer rates, the ...

New research has uncovered how lipid-rich fluid in the abdomen, known as ascites, plays a central role in weakening the body's immune response in advanced ovarian cancer. The findings offer new ...

Kerala has the highest number of cancer patients in the country. Why so?Our lifestyle is the main villain. Twenty-five years ...

US FDA approves Verastem’s Avmapki Fakzynja combo therapy to treat patients with KRAS-mutated recurrent low-grade serous ovarian cancer: Boston Saturday, May 10, 2025, 13:00 Hrs ...

Most ovarian cancers are diagnosed at later stages due to this lack of clear early warning signs,” says Dr Yogesh Kulkarni, ...

Lipid receptor SR-B1 identified as a potential immunotherapy target to boost NK cell antitumor response in advanced ovarian ...

A Ludwig Cancer Research study has identified a key mechanism by which advanced ovarian cancers suppress anti-tumor immune ...

The FDA has granted accelerated approval to the combination therapy of avutometinib and defactinib (Avmapki Fakzynja Co-pack) ...